Nuro partners with CVS on autonomous prescription deliveries
Nuro announced it is working with CVS Pharmacy to test prescription delivery in the Houston market. In a blog post written by the company, it detailed that while many of Americans’ daily lives have changed due to the COVID-19 pandemic, one thing hasn’t changed: needing prescription medication.
“We are seeing an increased demand for prescription delivery,” said Ryan Rumbarger, Senior Vice President of Store Operations, CVS Health. “We want to give our customers more choice in how they can quickly access the medications they need when it’s not convenient for them to visit one of our pharmacy locations.”
Starting in this month, Nuro will begin using its fleet of autonomous vehicles to deliver prescriptions and essentials across three zip codes in Houston, Texas.
“Today, we are excited to expand into an entirely new vertical: health,” said Dave Ferguson, Nuro’s Co-Founder and President.
To begin, CVS customers in the Houston pilot area can place prescription orders along with their non-prescription items on CVS.com or via the company’s Mobile Pharmacy app. If they select the autonomous delivery option, one of Nuro’s autonomous Prius vehicles will deliver the purchase curbside at the customer’s address within three hours. To ensure the security of their prescriptions, customers will need to confirm their identification to unlock their delivery when the vehicle arrives. During the pilot, deliveries will be free to all CVS Pharmacy customers.
According to the company, more than 76% of people in the U.S. live within five miles of a CVS Pharmacy, and, every day, it serves 4.5 million customers across the country. Additionally, it says that it has been at the forefront of delivery innovation as it was the first company to make prescription home-delivery a nationwide option in 2018.
Nuro added that while the service will begin with its autonomous Prius fleet to make deliveries, the shift to making deliveries with its R2 custom-built delivery bot will eventually occur.
For more information, visit nuro.ai.